ARaymond invests €66M in new production site for ARaymondlife

ARaymond is investing €66 million in a new production site in northern Isère, France, to increase capacity for RayDyLyo closures to 250 million parts per annum. The facility will be 14,000 m2 and is expected to be operational in early 2025, with workforce growing to 350.

“By investing in a new production facility, we are assuring our current and future customers that we have the capacity to produce in large quantities and supply the entire market.”pharmaceuticalmanufacturer.media

• 1 source
• pharmaceuticalmanufacturer.mediaAraymond Invest €66 Million in ARaymondLife - European Pharmaceutical ManufacturerEuropean Pharmaceutical Manufacturer MagazineJan 25, 2024

Summarized from public sources; check the original articles before acting on it.